Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments

(2009) Michael Schotsaert et al.   Expert Review of Vaccines

A Live Attenuated H1N1 M1 Mutant Provides Broad Cross‐Protection against Influenza A Viruses, Including Highly Pathogenic A/Vietnam/1203/2004, in Mice

(2009) Hang Xie et al.   JOURNAL OF INFECTIOUS DISEASES

Neuraminidase Stalk Length and Additional Glycosylation of the Hemagglutinin Influence the Virulence of Influenza H5N1 Viruses for Mice

(2009) Y. Matsuoka et al.   JOURNAL OF VIROLOGY

The Special Neuraminidase Stalk-Motif Responsible for Increased Virulence and Pathogenesis of H5N1 Influenza A Virus

(2009) Hongbo Zhou et al.   PLoS One

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine

(2009) G. Galli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets

(2009) Heather L. Forrest et al.   VACCINE

Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine

(2008) Benoît Baras et al.   PLoS One

Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens

(2008) Dominick J. Laddy et al.   PLoS One

A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses

(2008) M.-W. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA